Millisecond annealing (MSA) achieves increased dopant activation and suppresses short-channel effects after junction implantations. In this paper, we will explore ways to optimize conventional spike anneal processes on dopants activation management.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: